|
US6267968B1
|
|
MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
|
|
US2002010132A1
|
|
Compositions of muramyl peptides inhibiting the replication of hiv
|
|
FR2730936A1
|
|
Vaccine with increased immunogenicity
|
|
FR2732604A1
|
|
Derivatives and conjugates of mdp having stimulatory activity of hematopoietic function and compositions containing them
|
|
FR2730935A1
|
|
Vaccine with increased immunogenicity
|
|
FR2724845A1
|
|
Muramyl peptides compositions capable of inhibiting up to 100% replication of an acquired immuno deficiency virus, such as hiv
|
|
EP0689449A1
|
|
Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
|
|
FR2715305A1
|
|
Diesters of muramyl peptides in an oral form.
|
|
AU4331893A
|
|
Humoral immunity and cell mediation adjuvant composition inducing no response to auto-antigenic determinants
|
|
FR2703251A1
|
|
Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.
|
|
FR2702659A1
|
|
Compositions for application in human therapy, characterized by the association of a muramyl-peptide with a cytokine.
|
